Drug Trial Radar · NCT07925450
Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Sep 13, 2023
Primary completion
Mar 13, 2029
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- Weill Medical College of Cornell UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Children and young adults with Crohn's disease may develop iron deficiency anemia, a condition in which low iron levels reduce the number of healthy red blood cells. This study aims to develop and test a model to help identify which iron treatment approached are most effective for these patients. Researchers will examine laboratory results, disease activity, treatment information, and information about bacteria in the digestive tract. Participants will be followed over time, and questionnaires will assess iron supplement use and related symptoms. The findings may help guide iron treatment for children and young adults with Crohn's disease.
Conditions
- Crohn's Disease
- Iron Deficiency Anemia
Interventions
Iron (ferrous sulfate)Drug
Iron supplementation for treatment of iron deficiency anemia. The dose, schedule, and route are determined by the assigned study arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Hemoglobin LevelTime frame: At routine follow-up visits typically every 4 to 12 weeks, for up to 3 years after enrollment.
- Median MCV (Mean Corpuscular Volume)Time frame: At routine follow-up visits, typically every 4-12 weeks, for up to 3 years after enrollment.
- Median Serum Iron LevelTime frame: Approximately every 6 months during follow-up, for up to 3 years after enrollment.
- Median Iron SaturationTime frame: Approximately every 6 months during follow-up, for up to 3 years after enrollment.
- Median Ferritin LevelTime frame: Approximately every 6 months during follow-up for up to 3 years.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Weill Cornell Medicine
New York, New York · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.